Biogen Plans Leases Laboratory-Operations Center In Cambridge, Massachusetts
04/02/2015
Biogen develops, markets and manufactures therapies for people living with serious neurological, autoimmune and hematologic disorders, and is among the largest and fastest growing global life science companies based in Massachusetts. It will use this new space to expand its drug discovery efforts in this core life science district.
With the lease of the fifth floor to Biogen, BioMed Realty has fully leased the 417,000 square foot 301 Binney Street property. Biogen joins Ironwood Pharmaceuticals and Living Proof located at this prime laboratory and office building.
"BioMed Realty is pleased to welcome Biogen to our growing list of tenants in Cambridge, and we look forward to building a long relationship with such a strong player in the Kendall Square research community," said Bill Kane, Senior Vice President for BioMed Realty in Boston/Cambridge. "We are seeing a growing demand for life science real estate, especially quality laboratory space, here in Cambridge, and we are focused on developing and leasing this unique type of real estate to companies like Biogen, Baxter Healthcare and the growing number of new biotech companies seeking to develop breakthrough therapies in strategic locations."
The lease of 80,000 square feet with Biogen comes after recent announcements of leases to Reed Elsevier and Akamai Technologies totaling just over 100,000 square feet at the recently renovated 50 Hampshire property. These leases reflect the strong demand for lab and office space in Cambridge market, BioMed officials said.
Project Announcements
Bartlett Group Plans Strathcona County, Alberta, Headquarters-Manufacturing Operations
10/11/2024
Mart Frozen Foods Establishes Rupert, Idah, Production Operations
10/11/2024
Verst Group Logistics Expands Boone County, Kentucky, Operations
10/11/2024
Afton Scientific Expands Albemarle County, Virginia, Manufacturing Operations
10/10/2024
Eli Lilly and Company Expands Lebanon, Indiana, Operations
10/09/2024
Johnson & Johnson Plans Wilson, North Carolina, Pharmaceutical Manufacturing Operations
10/08/2024
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Cold Storage: The Next Big Thing in Industrial Real Estate
Q3 2024
-
What the Latest EPA PFAS Rule Means for Site Due Diligence
Q3 2024
-
Reaching for the Stars: Space Industry Creating Opportunities Across the Country
Q3 2024
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
Mitigating Site Risks for Industrial Projects
Q3 2024